• OPEN AN ACCOUNT
Indian Indices
Nifty
22,419.95 -150.40
(-0.67%)
Sensex
73,730.16 -609.28
( -0.82%)
Bank Nifty
48,201.05 -293.90
( -0.61%)
Nifty IT
33,666.20 111.80
( 0.33%)
Global Indices
Nasdaq
15,927.90 316.14
(2.03%)
Dow Jones
38,239.66 153.86
(0.40%)
Hang Seng
17,651.15 366.61
(2.12%)
Nikkei 225
37,934.76 306.28
(0.81%)
Forex
USD-INR
83.32 0.01
(0.01%)
EUR-INR
89.30 0.19
(0.22%)
GBP-INR
104.10 0.39
(0.38%)
JPY-INR
0.54 0.00
(-0.34%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
474.522963
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
78.34
106860.39
EPS(TTM)
Face Value()
Div & Yield %
51.38
2
0.75
 

Sharp India Ltd
Sharp India Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Jan 25,2024
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015 we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee the Board of Directors at their Meeting held on 25 January 2024 has approved- 1. Appointment of Mr. Makarand Date as Additional Non Independent Director wef 25 January 2024 and as Managing Director wef 1 February 2024 subject to approval of Members by Postal Ballot 2. Appointment of Mr. Jaideep Palsule as Chief Financial Officer of the Company wef 25th January 2024. 3. Resignation of Mr. Masahiko Nakagawasai from Directorship-Managing Directorship wef 31 Janaury 2024.